🆕 HOW TO MAKE A #DIAGNOSIS OF #LUPUS ?!? is the most common question 🧐 I get ➡️ Well, certainly NOT ⛔ by checking ✔️ if you have at least 4 criteria 📑 on a list ! #SLE diagnosis is a complex process 👨‍🎓 and requires expertise. Ask your #rheumatologist 👍 if you are unsure 🏥.

✅ Check the REAL-World treatment patterns of the #lupus patients included in the AZ-SPOCS cohort. The proportion on #glucocorticoids >5 mg/day ranged from ~20% to 33% throughout the study. We need to do better 😅 and be more proactive to spare GCs 💪

RT @LupusAcademy: Join us for the 14th Annual Meeting of the Lupus Academy, held 9–11 October 2025 in Berlin, Germany! This year we will al…

@abdelhamed012 Ohhh but this is my slide you have taken, and elegantly cut just my name at the bottom. Congratulations for your great manners, Sir 👍

RT @Lupusreference: ✅ Check my summary slide ⬇️ on the #obinutuzumab phase 3 (#REGENCY) trial in #lupus #nephritis 😉

RT @Lupusreference: 🚨 The #REGENCY phase 3 trial of #obinutuzumab in #Lupus #nephritis has just been published in the NEJM!!! DOWNLOAD LINK…

✅ Check my summary slide ⬇️ on the #obinutuzumab phase 3 (#REGENCY) trial in #lupus #nephritis 😉

RT @KhaledAlderaan: It was my pleasure to chair a session with Prof @Lupusreference in @ssrsa_org annual meeting I’m deeply grateful for y…

RT @SindhuJohnson5: Thank you to @ssrsa_org President & former @UofTRheum #Lupus fellow @rayes_dr for hosting a wonderful evening with @A_a…

🚨 The #REGENCY phase 3 trial of #obinutuzumab in #Lupus #nephritis has just been published in the NEJM!!! DOWNLOAD LINK:

RT @A_alkhalaf143: Honor to have you with us Laurent Arnaud @Lupusreference in our 11th annual conference of Saudi society for rheumatology…

✅ Thank you very much - شُكْرا جَزِيلا to the Saoudi Society for #Rheumatology, for the very kind invitation to talk about #Lupus at #SSRC2025 in Riyadh. It is pleasure to meet new colleagues and improve #SLE care altogether 👍

@ivan_padjen The English version of #SLAKE is now fully operational and tested. We will now add all other languages one by one 👍

✅ I have just finished preparing my #CORA2025 @autoimmunitymd debate supporting the idea that OF COURSE WE SHOULD NOT PRESCRIBE an early combination of treatments or TRIPLE THERAPY in #LUPUS #NEPHRITIS. Let's make the Standard Of Care GREAT again (SOCGA) 💪

✅ Thank you very much to the #Rheumatology Society of Saudi Arabia @ssrsa_org for the opportunity to participate to the 11th SSRC in Riyadh. It is always an amazing opportunity to move forward patient care for #lupus, meet new colleagues & strengthen collaboration with France 🇫🇷

@LatinZest Thanks! We will now go through internal validation by the #SLAKE group members, language upgrade (we have 15+ languages, including Spanish of course) and then external validation where anyone interested will be able to contribute, healthcare professionals and patients 👍

@LupusEurope @Lupus_Chile @ern_reconnet The main concept behind #SLAKE is that we need to evolve #patient education in #autoimmune diseases, by providing ONLINE & ON DEMAND educational content crafted to specific needs of individuals. By profiling knowledge across 11 domains #SLAKE enbles a personalized experience 👍

@DrErickZamora1 @LESAI_bot Sure 👍

✅ Check our latest paper ⬇️ Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic #Lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)